13.70EUR+2.54%Mkt Cap: 371.41M EURP/E: 23.66Last update: 2026-05-13
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company of…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)23.66
P/E (Forward)14.38
PEG6.37
P/B3.24
P/S3.34
EV/EBITDA15.36
EV/Revenue3.32
EPS (TTM)0.59
EPS (Forward)0.97
Cash Flow & Leverage
FCF Yield3.73%
FCF Margin12.47%
Operating CF30.23M EUR
CapEx (TTM)4.18M EUR
Net Debt/EBITDA-0.44
Net Debt-10.60M EUR
Technical
SMA 5016.95 (-19.2%)
SMA 20021.13 (-35.2%)
Beta0.85
S&P 52W Chg24.23%
Avg Vol (30d)93.13K
Avg Vol (10d)83.49K
Technical Indicators
RSI (14)29.9
MACD-1.1613
MACD Signal-1.1138
MACD Hist.-0.0475
BB Upper18.03 EUR
BB Middle15.04 EUR
BB Lower12.05 EUR
BB Width39.78%
ATR (14)0.5846 EUR
Vol Ratio (20d)0.58x
52W Range
13.302% of range29.80
52W High29.80 EUR
52W Low13.30 EUR
Profitability
Gross Margin70.94%
EBITDA Margin21.61%
Profit Margin15.88%
Oper. Margin8.43%
ROE15.18%
ROA11.56%
Revenue Growth4.60%
Earnings Growth-41.40%
Balance Sheet
Debt/Equity0.10
Current Ratio2.27
Quick Ratio1.76
Book Value/Sh4.312 EUR
Cash/Share0.7880 EUR
Dividends
Fwd Div Rate0.4000 EUR
Trail. Div Rate0.4400 EUR
Div. Yield2.04%
5Y Avg Yield1.21%
Payout Ratio67.85%
Ex-Div DateApr 11, 2025
Pay Date—
Splits
Last Split2:1
Split DateMar 20, 2020
Ownership
Shares Out.26.61M
Float26.72M
Insiders3.23%
Institutions58.32%
Analyst Consensus
Rating—
Target (Mean)19.38 EUR
Target Range15.00 EUR – 23.50 EUR
# Analysts4
Company
Market Cap371.41M EUR
Enterprise Value368.75M EUR
Revenue (TTM)111.05M EUR
Gross Profit77.80M EUR
Net Income (TTM)17.41M EUR
Revenue/Share4.158 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees246
Last Price13.70 EUR
CountryFI
SectorHealthcare
IndustryMedical Devices
ISINFI0009010912